TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

BridgeBio Pharma Inc (BBIO)

Healthcare Biotechnology
80.00 $
-0.2% vs. previous close
Closing price · As of: 3. Aug 2026

BridgeBio Pharma Inc (BBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 1,371 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet BBIO
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
504 655 546 849 794 665 919 882 1,080 998 936 1,371
433 588 478 783 616 445 721 695 912 839 754 1,178
302 505 376 475 547 266 681 541 749 643 570 880
384 543 435 520 587 266 681 541 757 646 587 940
8.6 5.2 1.8 235 0.7 0.5 4.7 115 77 117 139 205
20 17 17 -28 0.0 4.0 18 25 27 33
23
28 27 26 26 25 25 24 28 30 29 28 27
1,853 1,849 1,889 1,886 1,876 1,883 2,377 2,520 2,859 2,921 3,013 3,640
110 106 144 141 134 139 154 152 176 217 288 816
3.8 4.1 8.3 9.1 4.6 4.6 4.5 5.2 14 5.3 17 573
3.9 4.5 11 4.7 18 13 9.6 28 26 19 36 29
1,719 1,721 1,727 1,716 1,718 1,719 1,721 1,848 1,850 1,851 1,852 1,926
-1,362 -1,208 -1,354 -1,050 -1,093 -1,230 -1,468 -1,648 -1,788 -1,933 -2,077 -2,269
-2,215 -2,392 -2,561 -2,596 -2,669 -2,831 -3,096 -3,264 -3,446 -3,628 -3,821 -3,985
161 163 174 179 188 189 189 190 191 191 197 195

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?